Navigation Links
New Chemical May Halt HIV Infection

Infection from the Human Immunodeficiency Virus (HIV) can be blocked by a chemical called CSA-54, according to US based scientists. The disease is reportedly responsible for 25 million deaths across the world since 1981. //The lab tests of the chemical CSA-54 found that it disables the virus's ability to infect cells, according to BBC News.

The tests were carried out by researcher Derya Unutmaz, Associate Professor of Microbiology and Immunology at the Vanderbilt University School of Medicine, and his team. HIV specifically targets a type of immune cell called CD4+. The lab tests showed that CSA-54 blocked infection by disrupting HIV's ability to interact with the cells. The compound is expected to be equally effective against all the strains of the HIV virus.

The chemical was developed by the scientists at Brigham Young University, Utah, and is licensed to a company called Ceragenix Pharmaceuticals. Brigham Young University and Vanderbilt have jointly filed a patent on the compounds. The research is still at its early stages, and many years may pass before clinical trials are conducted.

Edited (IANS)
'"/>




Page: 1

Related medicine news :

1. Chemical in Gila monsters saliva yields Alzheimer drug
2. Chemical found in plants may be the treatment for leukemia
3. Chemicals in clear plastics can cause learning difficulties
4. Quitting Smoking Made Easy By Track Of New Chemical
5. Brain Chemical Identified For Drug Dependent Behavior
6. Block Immune System Chemical For Treating Asthma
7. Chest Pain Can Be Identified By New Tracer Chemical 30 Hours After Pain Relief
8. Chemical Signaling Helps Regulate Sensory Map Formation In The Brain
9. High Levels Of Cancer Chemical Found In Soft Drinks
10. Sedatives Derived From Chemicals Can Make Elderly Nervous
11. Chemicals causing Cancer Found In Soft Drinks In UK
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... global clinical supply services, today announced two key appointments and the opening of ... strategic growth plans in the Asia Pacific region. , Howard Kim has joined ...
(Date:5/26/2016)... , ... May 26, 2016 , ... In an effort to provide hair restoration information ... both Snapchat users and those who do not use the app. Dr. Mohebi, the founder ... page, Dr. Mohebi Live . , Dr. Mohebi says, “The positive response to ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... comprehensive treatment for eating disorders, is opening a brand new child and adolescent ... ages 8-17 and their families with even more specialized eating disorder treatment and ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 27, 2016 According to the ... is driving ambulatory blood pressure monitoring system market growth. ... their ability to respond to different pressure rates, leading ... lead to various cardiovascular disorders such as heart failure, ... diseases are growing in prevalence each year. WHO estimates ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharma company focused on the highly lucrative ... a substantial pipeline of potential first-in-class or best-in-class ... are in development with strategic partners. HCM,s profitable ... fast-growing domestic market. We expect progress of the ...
(Date:5/27/2016)... 2016 Kitov Pharmaceuticals ... on late-stage drug development, today announced the completion ... pivotal batches required for registration of KIT-302 with ... follows Kitov,s announcement in December 2015, ... its primary efficacy endpoint. "We are ...
Breaking Medicine Technology: